Clinical Trials Logo

Benign Thyroid Nodules clinical trials

View clinical trials related to Benign Thyroid Nodules.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03646383 Completed - Clinical trials for Benign Thyroid Nodules

Study of the Feasibility of Radiofrequency Ablation of Benign Thyroid Nodules

TRAF
Start date: January 29, 2019
Phase: N/A
Study type: Interventional

The purpose of the present protocol is to evaluate the response rate to treatment of these symptomatic benign nodules with radiofrequency as an alternative to surgical treatment. This thyroid nodules ablation with radiofrequency will be directed by a single percutaneous procedure guided by ultrasound. The procedure includes an ultrasound with percutaneously radiofrequency ablation of benign thyroid nodule. Clinical and ultrasonographic monitoring will last a year with consultations at 2 weeks (consultation only), 3 months, 6 months and 1 year (consultation, ultrasound TSH). The success of this procedure will be controlled with 3 successive ultrasounds the following year. The expected results are a decrease in the size of the nodule by at least 50% and a reduction in the functional and aesthetic discomfort, with less frequent complication than what is expected with surgery. The present study also intends to determine the medico economic impact of this technique compared to surgery.

NCT ID: NCT02658552 Completed - Clinical trials for Benign Thyroid Nodules

A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Benign Thyroid Nodules

Start date: October 2015
Phase: N/A
Study type: Interventional

To evaluate the short-term efficacy of high intensity focused ultrasound (HIFU) in the treatment of benign thyroid nodules

NCT ID: NCT02491502 Completed - Clinical trials for Benign Thyroid Nodules

Treatment of Benign Thyroid Nodules With FastScan HIFU

Start date: June 2015
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of the HIFU for the treatment of benign thyroid nodules with the FastScan version using assessment of patient experience and adverse event reporting.